AB Science (CHIX:ABP) Net Income From Continuing Operations : €-10.05 Mil (TTM As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is AB Science Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. AB Science's net income from continuing operations for the six months ended in Dec. 2023 was €0.36 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was €-10.05 Mil.

AB Science Net Income From Continuing Operations Historical Data

The historical data trend for AB Science's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AB Science Net Income From Continuing Operations Chart

AB Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-21.75

-15.05

-14.46

-13.62

-10.05

AB Science Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															-9.81	-13.62	-6.47	-10.41	0.36

AB Science Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-10.05 Mil.

AB Science (CHIX:ABP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (CHIX:ABp) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

ABSCF:USA AB:France

Address

3, Avenue George V, Paris, FRA, 75008

Website

https://www.ab-science.com

AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.

AB Science (CHIX:ABP) Headlines

From GuruFocus

Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets

By Marketwired Marketwired • 03-03-2020